Cancer in individuals with obesity and metabolic disorders. A preventable epidemic?

Fulvio Lonardo

Metabolism and Target Organ Damage ›› 2022, Vol. 2 ›› Issue (4) : 20

PDF
Metabolism and Target Organ Damage ›› 2022, Vol. 2 ›› Issue (4) : 20 DOI: 10.20517/mtod.2022.28
review-article

Cancer in individuals with obesity and metabolic disorders. A preventable epidemic?

Author information +
History +
PDF

Cite this article

Download citation ▾
Fulvio Lonardo. Cancer in individuals with obesity and metabolic disorders. A preventable epidemic?. Metabolism and Target Organ Damage, 2022, 2(4): 20 DOI:10.20517/mtod.2022.28

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Centers for Disease Control and Prevention (U.S.). MMWR. Morbidity and mortality weekly report, Vol. 66, no. 50, December 22, 2017. Available from: https://stacks.cdc.gov/view/cdc/50243 [Last accessed on 25 Nov 2022]

[2]

CDC. Adult obesity facts. Available from: https://www.cdc.gov/obesity/data/adult.html [Last accessed on 25 Nov 2022]

[3]

WangYC,MarshT,BrownM.Health and economic burden of the projected obesity trends in the USA and the UK.Lancet2011;378:815-25

[4]

NgM,RobinsonM.Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013.Lancet2014;384:766-81 PMCID:PMC4624264

[5]

ZhouB,HajifathalianK.Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants.Lancet2016;387:1513-30 PMCID:PMC5081106

[6]

Centers for Disease Control and Prevention(CDC). National and state diabetes trends, 2021. Available from: https://www.cdc.gov/diabetes/library/reports/reportcard/national-state-diabetes-trends.html [Last accessed on 25 Nov 2022]

[7]

CalleEE,Walker-ThurmondK.Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.N Engl J Med2003;348:1625-38

[8]

ScullyT,LeRoithD.Obesity, type 2 diabetes, and cancer risk.Front Oncol2020;10:615375 PMCID:PMC7884814

[9]

LonardoF.Metabolism and cancer-select topics.Metab Target Organ Damage2022;2:8

[10]

LonardoA.The “obese liver” and gastrointestinal cancer risk.Transl Gastroenterol Hepatol2020;5:44 PMCID:PMC7063505

[11]

AllenAM,MaraKC,TherneauTM.The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - a longitudinal cohort study.J Hepatol2019;71:1229-36 PMCID:PMC6921701

[12]

Mauvais-jarvisF,BarnesPJ.Sex and gender: modifiers of health, disease, and medicine.Lancet2020;396:565-82 PMCID:PMC7440877

[13]

SimonTG,KhaliliH,LudvigssonJF.Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort.Gut2021;70:1375-82 PMCID:PMC8185553

[14]

Lorenzo A, Romano L, Di Renzo L, Di Lorenzo N, Cenname G, Gualtieri P. Obesity: a preventable, treatable, but relapsing disease.Nutrition2020;71:110615

[15]

YuSJ,KimD et al.Visceral obesity predicts significant fibrosis in patients with NAFLD.Medicine2015;94:e2159

[16]

ShiYX,QiuHN.Visceral fat area to appendicular muscle mass ratio as a predictor for nonalcoholic fatty liver disease independent of obesity.Scand J Gastroenterol2021;56:312-20

[17]

MarchesiniG,Cortez-PintoH.Adipose tissue-associated cancer risk: is it the fat around the liver, or the fat inside the liver?.J Hepatol2019;71:1073-5

[18]

LindL,RisérusU.The plasma metabolomic profile is differently associated with liver fat, visceral adipose tissue, and pancreatic fat.J Clin Endocrinol Metab2021;106:e118-29 PMCID:PMC7765636

[19]

RaoS,OhshiroK.β2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development.Sci Transl Med2021;13:eabk2267 PMCID:PMC8941321

[20]

TumminiaA,ParisiM.Adipose tissue, obesity and adiponectin: role in endocrine cancer risk.Int J Mol Sci2019;20:2863 PMCID:PMC6628240

[21]

YanaiH.Beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression: mechanisms and perspectives.Int J Mol Sci2019;20:1190 PMCID:PMC6429491

[22]

RojasE,BolliP et al.The role of adiponectin in endothelial dysfunction and hypertension.Curr Hypertens Rep2014;16:463

[23]

2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the global burden of disease study 2019.Lancet2022;400:569-91

[24]

AminianA,Al-KurdA.Association of bariatric surgery with cancer risk and mortality in adults with obesity.JAMA2022;327:2423-33 PMCID:PMC9166218

[25]

SjöströmL,SjöströmCD.Swedish obese subjects studyEffects of bariatric surgery on mortality in Swedish obese subjects.N Engl J Med2007;357:741-52

[26]

SafaeiM,DrissM,Shapi'iA.A systematic literature review on obesity: understanding the causes & consequences of obesity and reviewing various machine learning approaches used to predict obesity.Comput Biol Med2021;136:104754

[27]

MüllerMJ,AsbeckI,GrundA.Prevention of obesity-is it possible?.Obes Rev2001;2:15-28

[28]

Centers for Disease Control and Prevention(CDC). Proven strategies. Available from: https://www.cdc.gov/nccdphp/dnpao/proven-strategies.html [Last accessed on 25 Nov 2022]

[29]

PalaciosC,ArrietaA,TapiaR.Obesity in Latin America, a scoping review of public health prevention strategies and an overview of their impact on obesity prevention.Public Health Nutr2021;24:5142-55

[30]

CaballeroB.Humans agains obesity: who will win?.Adv Nutr2019;10:S4-9

[31]

ColeHM.The war against tobacco: 50 years and counting.JAMA2014;311:131-2 PMCID:PMC4465196

[32]

YiC,WanM,ChengX.Statins intake and risk of liver cancer: a dose-response meta analysis of prospective cohort studies.Medicine2017;96:e7435 PMCID:PMC5502182

[33]

JeongGH,KimJY.Statin and cancer mortality and survival: an umbrella systematic review and meta-analysis.J Clin Med2020;9:326 PMCID:PMC7074262

AI Summary AI Mindmap
PDF

21

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/